All In Biotech

Free tool

FAERS Monitor: Uptravi

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 207947 or its brand name (Uptravi, Selexipag). Reports on generic versions are filed under their own applications.

Reports

26,100

Serious

19,535

75% of reports

Hospitalization

12,787

Death reported

4,907

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • headache6,834
  • diarrhoea5,244
  • dyspnoea4,841
  • nausea4,153
  • fatigue2,651
  • death2,559
  • pain in jaw2,455
  • dizziness2,338
  • pain2,250
  • pain in extremity2,149
  • myalgia2,008
  • vomiting1,970
  • pneumonia1,832
  • malaise1,818
  • hypotension1,748

Reports by year received

View as table
YearReports
20122
20132
20145
201526
20161,557
20172,388
20183,027
20193,219
20203,248
20212,807
20222,261
20232,301
20242,240
20251,807
20261,210

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,028,059 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pain in jawSignal2,45576.473.4166,945
myalgiaSignal2,0089.69.215,442
headacheSignal6,8348.98.748,641
hypotensionSignal1,7487.16.89,120
dyspnoeaSignal4,8416.96.825,081
diarrhoeaSignal5,2446.66.425,450
pain in extremitySignal2,1495.95.78,828
pneumoniaSignal1,8324.64.45,174
nauseaSignal4,1534.24.110,648
dizzinessSignal2,3383.83.64,894
vomitingSignal1,9703.43.23,372
malaiseSignal1,8183.43.23,046
painSignal2,2503.02.82,993
fatigueSignal2,6512.72.73,053
deathSignal2,5592.42.32,166

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.